XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Shares [Member]
Total Teva Shareholders' Equity [Member]
Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2021 $ 11,244 $ 57 $ 27,561 $ (10,529) $ (2,683) $ (4,128) $ 10,278 $ 966
Beginning balance, shares at Dec. 31, 2021   1,209            
Net income (loss) (1,211)     (1,187)     (1,187) (24)
Other comprehensive income (loss) (268)       (118)   (118) (150)
Issuance of Shares, value 1   1       1  
Issuance of Shares, shares   7            
Stock-based compensation expense 63   63       63  
Ending balance at Jun. 30, 2022 9,828 $ 57 27,625 (11,716) (2,801) (4,128) 9,037 791
Ending balance, shares at Jun. 30, 2022   1,216            
Beginning balance at Mar. 31, 2022 10,260 $ 57 27,587 (11,484) (2,687) (4,128) 9,344 916
Beginning balance, shares at Mar. 31, 2022   1,216            
Net income (loss) (259)     (232)     (232) (27)
Other comprehensive income (loss) (212)       (114)   (114) (98)
Stock-based compensation expense 39   39       39  
Ending balance at Jun. 30, 2022 9,828 $ 57 27,625 (11,716) (2,801) (4,128) 9,037 791
Ending balance, shares at Jun. 30, 2022   1,216            
Beginning balance at Dec. 31, 2022 8,691 $ 57 27,688 (12,882) (2,838) (4,128) 7,897 794
Beginning balance, shares at Dec. 31, 2022   1,217            
Net income (loss) (1,136)     (1,068)     (1,068) (68)
Other comprehensive income (loss) 92       161   161 (69)
Issuance of Shares, shares   10            
Stock-based compensation expense 62   62       62  
Ending balance at Jun. 30, 2023 7,708 $ 57 27,748 (13,950) (2,677) (4,128) 7,052 656
Ending balance, shares at Jun. 30, 2023   1,227            
Beginning balance at Mar. 31, 2023 8,612 $ 57 27,719 (13,086) (2,701) (4,128) 7,860 751
Beginning balance, shares at Mar. 31, 2023   1,226            
Net income (loss) (898)     (863)     (863) (35)
Other comprehensive income (loss) (35)       25   25 (60)
Issuance of Shares, shares   1            
Stock-based compensation expense 30   30       30  
Ending balance at Jun. 30, 2023 $ 7,708 $ 57 $ 27,748 $ (13,950) $ (2,677) $ (4,128) $ 7,052 $ 656
Ending balance, shares at Jun. 30, 2023   1,227